Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • October 20, 2017

    J&J Wins Toss Of $417M Talc Cancer Verdict In Calif.

    A California judge on Friday tossed a jury award of $417 million from Johnson & Johnson to a woman who claimed the company's baby powder gave her ovarian cancer, finding the plaintiff relied on speculative expert testimony that failed to link talcum powder to cancer.

  • October 20, 2017

    Abbott Can't Escape Failure-To-Warn Claims In Depakote Suit

    An Illinois federal judge on Friday denied a bid by Abbott Laboratories to toss a suit alleging it failed to properly warn doctors about the risk of birth defects like spina bifida from the use of Depakote, rejecting the drugmaker's assertion that merely listing the probability of the defect on the drug's label was sufficient under Maryland law.

  • October 20, 2017

    Boehringer Sues Drugmakers To Block Generic Gilotrif Plans

    German drugmaker Boehringer Ingelheim Pharmaceuticals Inc. filed a pair of patent infringement suits Friday in New Jersey federal court over bids by Sandoz Inc. and Sun Pharmaceutical Industries to market generic versions of its cancer therapy drug.

  • October 20, 2017

    If J&J Talc Had Asbestos, It Could Cause Cancer, Expert Says

    If Johnson & Johnson’s talcum powder products contained asbestos, a person using them on their child or on themselves could develop mesothelioma, a former Tulane pathology professor and asbestos expert testified in a California trial Friday for a woman alleging she developed the cancer in this way.

  • October 20, 2017

    Opioid Litigation Roundup: An Overview Of Major Cases

    State attorneys general, a Native American tribe and individual consumers are among the chorus of plaintiffs who've brought lawsuits against drugmakers, pharmacies and distributors allegedly responsible for epidemic levels of opioid abuse. Here, Law360 gives an overview of major pending opioid cases and how far they've progressed.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals